MedPath

Teen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1)

Completed
Conditions
Medication Adherence
Interventions
Other: Focus Group
Registration Number
NCT02910661
Lead Sponsor
Beth Foster
Brief Summary

The overall goal of the Teen Adherence in KidnEy transplant Improving Tracking TO Optimize Outcomes (TAKE-IT TOO) study is to adapt the successful TAKE-IT intervention, aimed at improving medication adherence in adolescent kidney transplant, for use in 'real world' clinical care. The specific aims of Stage 1 of this study are: (1) To understand the needs and preferences of stakeholders (kidney transplant recipients, parents, and healthcare professionals (HCP)) in order to optimize the TAKE-IT intervention for 'real world' use.

Detailed Description

TAKE-IT TOO is a prospective, 3-stage, sequential study using user-centered design techniques throughout. This entry describes Stage 1of TAKE-IT TOO. In Stage 1 we will conduct focus groups (FG) to gather data about the needs and preferences of stakeholders to inform adaptation of the Teen Adherence in Kidney transplant Effectiveness of Intervention Trial (TAKE-IT) intervention and features of a novel e-pillbox and adherence-tracking website. The protocols for Stages 2 and 3 will be submitted separately.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
95
Inclusion Criteria
  • Patients: Prevalent kidney-only transplant recipients 12-24 y, ≥3 months post-transplant.
  • Parents: Parents of prevalent kidney-only transplant recipients 12-17 y (followed in a participating transplant center). Parents will be eligible to participate even if their child does not participate.
  • HCP: transplant healthcare professionals (including representatives from variety of disciplines typically involved in promoting medication adherence)
Exclusion Criteria
  • Patients: Individuals with significant neurocognitive disabilities limiting their ability to understand and participate in their own care. Multiorgan transplant recipients. Patient or parent unable to communicate in English or French (Montreal only)
  • Parents: Parents of patients 18-24 years old will be excluded

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ParentsFocus GroupFocus groups (n=6-8/group) will be conducted at Pittsburgh \& Seattle. Focus groups will be conducted with parents clustered by patient age (12-14 y. \& 15- 17 y.)
Healthcare professionalsFocus GroupOne focus group of healthcare professionals (HCP) representing the variety of multidisciplinary transplant team members at each center will be convened. We will aim for 4-8 HCP per group; however, the number will be dictated by the composition and size of the transplant team at each site. We expect variability in the organization of care across the 7 sites, which represent 2 countries and small to large program sizes; including all sites will capture this variability.
PatientsFocus GroupFocus groups (n=6-8/group) will be conducted at 4 sites selected to maximize racial diversity and to ensure availability of adequate numbers in each age group (Montreal (incl. the McGill University Health Centre (MUHC), Centre Hospitalier Universitaire-Ste. Justine \& CHUM ), Pittsburgh, Seattle, and St. Louis). Separate focus groups will be conducted with patients clustered by patient age to maximize homogeneity in developmental stage. Purposive sampling will be employed to ensure that each focus group includes patients with combinations of characteristics that are likely to account for variation in perspectives, including the major racial and ethnic groups, both sexes, time since transplant, and level of adherence.
Primary Outcome Measures
NameTimeMethod
Stakeholders' needs and preferences90 minutes

needs and preferences of young kidney transplant recipients, their parents, and HCP regarding electronic monitoring and adherence interventions

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (9)

Temple University

🇺🇸

Philadelphia, Pennsylvania, United States

Montreal Children's Hospital of the MUHC

🇨🇦

Montreal, Quebec, Canada

Centre Hospitalier de l'Université de Montréal

🇨🇦

Montreal, Quebec, Canada

CHU Ste-Justine

🇨🇦

Montreal, Quebec, Canada

BC Children's Hospital

🇨🇦

Vancouver, British Columbia, Canada

University of Toronto Hospital for Sick Children

🇨🇦

Toronto, Ontario, Canada

Children's Hospital St-Louis

🇺🇸

Saint Louis, Missouri, United States

Seattle Children's Hospital

🇺🇸

Seattle, Washington, United States

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath